A systematic review and meta-analysis published in Infections Disease Reports highlighted increased attack rates, incidence rates, and case fatality ratios associated with RSV in bone marrow transplant recipients. Matteo Riccò, MD, and colleagues conducted a systematic review, searching three medical databases for eligible observational studies. Overall, the 30 studies included 20,067 bone marrow transplants and 821 RSV infections, as well as 351 lower respiratory tract infections and 78 RSV-related deaths. The study reported a pooled attack rate of 5.40%, with an incidence rate of 14.77 cases per 1,000 person-years and a case fatality ratio of 7.28%. Relative to RSV, influenza, adenovirus, and human metapneumovirus demonstrated reduced risks for respiratory infection, with relative risks of 0.518, 0.679, and 0.536, respectively. The researchers suggest that a preventive approach to RSV among bone marrow transplant recipients include enhanced testing protocols, with regular screening for respiratory pathogens in newly admitted patients.